199 related articles for article (PubMed ID: 33881228)
1. Protein Mannosylation as a Diagnostic and Prognostic Biomarker of Lupus Nephritis: An Unusual Glycan Neoepitope in Systemic Lupus Erythematosus.
Alves I; Santos-Pereira B; Dalebout H; Santos S; Vicente MM; Campar A; Thepaut M; Fieschi F; Strahl S; Boyaval F; Vizcaíno R; Silva R; Holst-Bernal S; Vasconcelos C; Santos L; Wuhrer M; Marinho A; Heijs B; Pinho SS
Arthritis Rheumatol; 2021 Nov; 73(11):2069-2077. PubMed ID: 33881228
[TBL] [Abstract][Full Text] [Related]
2. Association between immunoglobulin G N-glycosylation and lupus nephritis in female patients with systemic lupus erythematosus: a case-control study.
Lu X; Wang L; Wang M; Li Y; Zhao Q; Shi Y; Zhang Y; Wang Y; Wang W; Ji L; Hou H; Li D
Front Immunol; 2023; 14():1257906. PubMed ID: 37809087
[TBL] [Abstract][Full Text] [Related]
3. Deep Phenotyping of Urinary Leukocytes by Mass Cytometry Reveals a Leukocyte Signature for Early and Non-Invasive Prediction of Response to Treatment in Active Lupus Nephritis.
Bertolo M; Baumgart S; Durek P; Peddinghaus A; Mei H; Rose T; Enghard P; Grützkau A
Front Immunol; 2020; 11():256. PubMed ID: 32265898
[TBL] [Abstract][Full Text] [Related]
4. Alteration of N-glycosylation in the kidney in a mouse model of systemic lupus erythematosus: relative quantification of N-glycans using an isotope-tagging method.
Hashii N; Kawasaki N; Itoh S; Nakajima Y; Kawanishi T; Yamaguchi T
Immunology; 2009 Mar; 126(3):336-45. PubMed ID: 18710403
[TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factor binding protein-2 as a novel biomarker for disease activity and renal pathology changes in lupus nephritis.
Ding H; Kharboutli M; Saxena R; Wu T
Clin Exp Immunol; 2016 Apr; 184(1):11-8. PubMed ID: 26616478
[TBL] [Abstract][Full Text] [Related]
6. Clinical application of protein biomarkers in lupus erythematosus and lupus nephritis.
Qi S; Chen Q; Xu D; Xie N; Dai Y
Lupus; 2018 Sep; 27(10):1582-1590. PubMed ID: 29720035
[TBL] [Abstract][Full Text] [Related]
7. Urinary levels of sirtuin-1 associated with disease activity in lupus nephritis.
Olivares D; Perez-Hernandez J; Forner MJ; Perez-Soriano C; Tormos MC; Saez GT; Chaves FJ; Redon J; Cortes R
Clin Sci (Lond); 2018 Mar; 132(5):569-579. PubMed ID: 29440621
[TBL] [Abstract][Full Text] [Related]
8. Metabolic Markers and Association of Biological Sex in Lupus Nephritis.
Wolf B; Blaschke CRK; Mungaray S; Weselman BT; Stefanenko M; Fedoriuk M; Bai H; Rodgers J; Palygin O; Drake RR; Nowling TK
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003679
[TBL] [Abstract][Full Text] [Related]
9. Urinary dedifferentiated podocytes as a non-invasive biomarker of lupus nephritis.
Perez-Hernandez J; Olivares MD; Forner MJ; Chaves FJ; Cortes R; Redon J
Nephrol Dial Transplant; 2016 May; 31(5):780-9. PubMed ID: 26932688
[TBL] [Abstract][Full Text] [Related]
10. Pathogenesis and significance of glomerular C4d deposition in lupus nephritis: activation of classical and lectin pathways.
Kim MK; Maeng YI; Lee SJ; Lee IH; Bae J; Kang YN; Park BT; Park KK
Int J Clin Exp Pathol; 2013; 6(10):2157-67. PubMed ID: 24133594
[TBL] [Abstract][Full Text] [Related]
11. Discovery and Qualification of Candidate Urinary Biomarkers of Disease Activity in Lupus Nephritis.
Anania VG; Yu K; Pingitore F; Li Q; Rose CM; Liu P; Sandoval W; Herman AE; Lill JR; Mathews WR
J Proteome Res; 2019 Mar; 18(3):1264-1277. PubMed ID: 30525646
[TBL] [Abstract][Full Text] [Related]
12. Plasma C4d Correlates With C4d Deposition in Kidneys and With Treatment Response in Lupus Nephritis Patients.
Martin M; Trattner R; Nilsson SC; Björk A; Zickert A; Blom AM; Gunnarsson I
Front Immunol; 2020; 11():582737. PubMed ID: 33133102
[TBL] [Abstract][Full Text] [Related]
13. Human Epididymis Protein 4: A Novel Biomarker for Lupus Nephritis and Chronic Kidney Disease in Systemic Lupus Erythematosus.
Yang Z; Zhang Z; Qin B; Wu P; Zhong R; Zhou L; Liang Y
J Clin Lab Anal; 2016 Nov; 30(6):897-904. PubMed ID: 27075413
[TBL] [Abstract][Full Text] [Related]
14. The Kidney Biopsy in Systemic Lupus Erythematosus: A View of the Past and a Vision of the Future.
Ayoub I; Cassol C; Almaani S; Rovin B; Parikh SV
Adv Chronic Kidney Dis; 2019 Sep; 26(5):360-368. PubMed ID: 31733720
[TBL] [Abstract][Full Text] [Related]
15. Worse Renal Presentation and Prognosis in Initial-Onset Lupus Nephritis than Early-Onset Lupus Nephritis.
Kwon OC; Park JH; Lee SW; Song JJ; Park YB; Park MC
Yonsei Med J; 2020 Nov; 61(11):951-957. PubMed ID: 33107238
[TBL] [Abstract][Full Text] [Related]
16. Discovery of NEU1 as a candidatedone. renal biomarker for proliferative lupus nephritis chronicity.
Mao Z; Tan Y; Yu F; Zhao M
Lupus Sci Med; 2021 Dec; 8(1):. PubMed ID: 34872988
[TBL] [Abstract][Full Text] [Related]
17. Resistin as a potential marker of renal disease in lupus nephritis.
Hutcheson J; Ye Y; Han J; Arriens C; Saxena R; Li QZ; Mohan C; Wu T
Clin Exp Immunol; 2015 Mar; 179(3):435-43. PubMed ID: 25345756
[TBL] [Abstract][Full Text] [Related]
18. Analysis of interleukin-17 and interleukin-23 for estimating disease activity and predicting the response to treatment in active lupus nephritis patients.
Dedong H; Feiyan Z; Jie S; Xiaowei L; Shaoyang W
Immunol Lett; 2019 Jun; 210():33-39. PubMed ID: 31004679
[TBL] [Abstract][Full Text] [Related]
19. Utility of urinary transferrin and ceruloplasmin in patients with systemic lupus erythematosus for differentiating patients with lupus nephritis.
Urrego T; Ortiz-Reyes B; Vanegas-García AL; Muñoz CH; González LA; Vásquez G; Gómez-Puerta JA
Reumatol Clin (Engl Ed); 2020; 16(1):17-23. PubMed ID: 29530762
[TBL] [Abstract][Full Text] [Related]
20. Urine biomarkers of chronic kidney damage and renal functional decline in childhood-onset systemic lupus erythematosus.
Brunner HI; Gulati G; Klein-Gitelman MS; Rouster-Stevens KA; Tucker L; Ardoin SP; Onel KB; Mainville R; Turnier J; Aydin POA; Witte D; Huang B; Bennett MR; Devarajan P
Pediatr Nephrol; 2019 Jan; 34(1):117-128. PubMed ID: 30159624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
